SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rachael A. Lewus, Nicholas E. Levy, Abraham M. Lenhoff, Stanley I. Sandler, A comparative study of monoclonal antibodies. 1. phase behavior and protein–protein interactions, Biotechnology Progress, 2015, 31, 1
  2. 2
    Lucrèce Nicoud, Marta Owczarz, Paolo Arosio, Massimo Morbidelli, A multiscale view of therapeutic protein aggregation: A colloid science perspective, Biotechnology Journal, 2015, 10, 3
  3. 3
    Natalie Rakel, Katharina Christin Bauer, Lara Galm, Juergen Hubbuch, From osmotic second virial coefficient (B22) to phase behavior of a monoclonal antibody, Biotechnology Progress, 2015, 31, 2
  4. 4
    Dejan Arzenšek, Drago Kuzman, Rudolf Podgornik, Hofmeister Effects in Monoclonal Antibody Solution Interactions, The Journal of Physical Chemistry B, 2015, 150724093945007

    CrossRef

  5. 5
    Natalie Rakel, Lara Galm, Katharina Christin Bauer, Juergen Hubbuch, Influence of macromolecular precipitants on phase behavior of monoclonal antibodies, Biotechnology Progress, 2015, 31, 1
  6. 6
    Dariusch Hekmat, Large-scale crystallization of proteins for purification and formulation, Bioprocess and Biosystems Engineering, 2015, 38, 7, 1209

    CrossRef

  7. 7
    D. Roberts, R. Keeling, M. Tracka, C. F. van der Walle, S. Uddin, J. Warwicker, R. Curtis, Specific Ion and Buffer Effects on Protein–Protein Interactions of a Monoclonal Antibody, Molecular Pharmaceutics, 2015, 12, 1, 179

    CrossRef

  8. 8
    Nicholas E. Levy, Kristin N. Valente, Leila H. Choe, Kelvin H. Lee, Abraham M. Lenhoff, Identification and characterization of host cell protein product-associated impurities in monoclonal antibody bioprocessing, Biotechnology and Bioengineering, 2014, 111, 5
  9. 9
    Natalie Rakel, Miriam Baum, Jürgen Hubbuch, Moving through three-dimensional phase diagrams of monoclonal antibodies, Biotechnology Progress, 2014, 30, 5
  10. 10
    Christopher J Roberts, Protein aggregation and its impact on product quality, Current Opinion in Biotechnology, 2014, 30, 211

    CrossRef

  11. 11
    Marco A. Blanco, Tatiana Perevozchikova, Vincenzo Martorana, Mauro Manno, Christopher J. Roberts, Protein–Protein Interactions in Dilute to Concentrated Solutions: α-Chymotrypsinogen in Acidic Conditions, The Journal of Physical Chemistry B, 2014, 118, 22, 5817

    CrossRef

  12. 12
    Ying Wang, Ramil F. Latypov, Aleksey Lomakin, Julie A. Meyer, Bruce A. Kerwin, Suresh Vunnum, George B. Benedek, Quantitative Evaluation of Colloidal Stability of Antibody Solutions using PEG-Induced Liquid–Liquid Phase Separation, Molecular Pharmaceutics, 2014, 11, 5, 1391

    CrossRef

  13. 13
    Christopher J. Roberts, Marco A. Blanco, Role of Anisotropic Interactions for Proteins and Patchy Nanoparticles, The Journal of Physical Chemistry B, 2014, 118, 44, 12599

    CrossRef

  14. 14
    D. Roberts, R. Keeling, M. Tracka, C. F. van der Walle, S. Uddin, J. Warwicker, R. Curtis, The Role of Electrostatics in Protein–Protein Interactions of a Monoclonal Antibody, Molecular Pharmaceutics, 2014, 11, 7, 2475

    CrossRef

  15. 15
    Harvey R. Johnson, Abraham M. Lenhoff, Characterization and Suitability of Therapeutic Antibody Dense Phases for Subcutaneous Delivery, Molecular Pharmaceutics, 2013, 130906090243008

    CrossRef

  16. 16
    Thomas M. Scherer, Cosolute Effects on the Chemical Potential and Interactions of an IgG1 Monoclonal Antibody at High Concentrations, The Journal of Physical Chemistry B, 2013, 117, 8, 2254

    CrossRef

  17. 17
    Dirk Hebel, Mark Ürdingen, Dariusch Hekmat, Dirk Weuster-Botz, Development and Scale up of High-Yield Crystallization Processes of Lysozyme and Lipase Using Additives, Crystal Growth & Design, 2013, 13, 6, 2499

    CrossRef

  18. 18
    Benjamin Smejkal, Neeraj J. Agrawal, Bernhard Helk, Henk Schulz, Marion Giffard, Matthias Mechelke, Franziska Ortner, Philipp Heckmeier, Bernhardt L. Trout, Dariusch Hekmat, Fast and scalable purification of a therapeutic full-length antibody based on process crystallization, Biotechnology and Bioengineering, 2013, 110, 9
  19. 19
    Elaheh Binabaji, Suma Rao, Andrew L. Zydney, Improved Method for Evaluating the Dead Volume and Protein–Protein Interactions by Self-Interaction Chromatography, Analytical Chemistry, 2013, 85, 19, 9101

    CrossRef

  20. 20
    Ying Wang, Aleksey Lomakin, Ramil F. Latypov, Jacob P. Laubach, Teru Hideshima, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson, George B. Benedek, Phase transitions in human IgG solutions, The Journal of Chemical Physics, 2013, 139, 12, 121904

    CrossRef

  21. 21
    Shantanu V. Sule, Craig D. Dickinson, Jirong Lu, Chi-Kin Chow, Peter M. Tessier, Rapid Analysis of Antibody Self-Association in Complex Mixtures Using Immunogold Conjugates, Molecular Pharmaceutics, 2013, 10, 4, 1322

    CrossRef

  22. 22
    Dirk Hebel, Sabine Huber, Bernd Stanislawski, Dariusch Hekmat, Stirred batch crystallization of a therapeutic antibody fragment, Journal of Biotechnology, 2013, 166, 4, 206

    CrossRef

  23. 23
    A. Quigley, J.Y.Y. Heng, J.M. Liddell, D.R. Williams, The accurate measurement of second virial coefficients using self-interaction chromatography: Experimental considerations, European Journal of Pharmaceutics and Biopharmaceutics, 2013, 85, 3, 1103

    CrossRef

  24. 24
    Ameya U. Borwankar, Aileen K. Dinin, Joshua R. Laber, April Twu, Brian K. Wilson, Jennifer A. Maynard, Thomas M. Truskett, Keith P. Johnston, Tunable equilibrium nanocluster dispersions at high protein concentrations, Soft Matter, 2013, 9, 6, 1766

    CrossRef

  25. 25
    Dejan Arzenšek, Drago Kuzman, Rudolf Podgornik, Colloidal interactions between monoclonal antibodies in aqueous solutions, Journal of Colloid and Interface Science, 2012, 384, 1, 207

    CrossRef

  26. 26
    Chakravarthy Narasimhan, Henryk Mach, Mohammed Shameem, High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspective, Therapeutic Delivery, 2012, 3, 7, 889

    CrossRef

  27. 27
    Y. Wang, A. Lomakin, T. Hideshima, J. P. Laubach, O. Ogun, P. G. Richardson, N. C. Munshi, K. C. Anderson, G. B. Benedek, Pathological crystallization of human immunoglobulins, Proceedings of the National Academy of Sciences, 2012, 109, 33, 13359

    CrossRef

  28. 28
    Shantanu V. Sule, Jason K. Cheung, Valentyn Antochshuk, Amardeep S. Bhalla, Chakravarthy Narasimhan, Steven Blaisdell, Mohammed Shameem, Peter M. Tessier, Solution pH That Minimizes Self-Association of Three Monoclonal Antibodies Is Strongly Dependent on Ionic Strength, Molecular Pharmaceutics, 2012, 9, 4, 744

    CrossRef

  29. 29
    Steven M Cramer, Melissa A Holstein, Downstream bioprocessing: recent advances and future promise, Current Opinion in Chemical Engineering, 2011, 1, 1, 27

    CrossRef

  30. 30
    Y. Wang, A. Lomakin, R. F. Latypov, G. B. Benedek, Phase separation in solutions of monoclonal antibodies and the effect of human serum albumin, Proceedings of the National Academy of Sciences, 2011, 108, 40, 16606

    CrossRef

  31. 31
    Tim J. Kamerzell, Reza Esfandiary, Sangeeta B. Joshi, C. Russell Middaugh, David B. Volkin, Protein–excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development, Advanced Drug Delivery Reviews, 2011, 63, 13, 1118

    CrossRef